The Proven Leader for Primary Periodic Paralysis Treatment

KEVEYIS® (dichlorphenamide) is a daily pill proven to treat and reduce Primary Periodic Paralysis (PPP) attack frequency, severity and duration.1,2

KEVEYIS® (dichlorphenamide) is proven to treat PPP1

KEVEYIS can help patients gain greater control over Primary Periodic Paralysis (PPP). It’s proven to reduce the frequency, severity and duration of attacks.1,2

When compared with a placebo in a 9-week study1,2:

“I went from about one [attack] a week to one a month since starting KEVEYIS.”

Paul, KEVEYIS Patient and PPP Mentor

GET SUPPORT

What is PPP?

PPP is a genetic condition that can be progressive and debilitating.3,4 It involves a group of rare channelopathies that manifest as recurrent attacks of muscle weakness or temporary paralysis often precipitated by triggers.

Ensuring you and your PPP patients never walk alone

Managing PPP takes more than dichlorphenamide alone. Our Xeris CareConnection™ experts have been supporting the PPP community since 2016. We’re ready to help your office and patients every step of the way. Here’s what makes us the proven leader for PPP:

“I assumed my first call with my PAM was only for educational purposes, but after I talked to him, I realized how much better I was feeling emotionally, just being able to have contact with someone who understood what I was going through.”

Dennis, KEVEYIS patient and PPP Mentor

PATIENT TESTIMONIALS

Real KEVEYIS patients share their stories

Hear from patients who gained greater control over PPP.

Paul
On KEVEYIS since 2017
“I went from about one [attack] a week to one a month since starting KEVEYIS.”

Paul
KEVEYIS patient
Hear more about Paul ➞
Kirsten
On KEVEYIS since 2016
“After starting KEVEYIS I have no attacks of full body paralysis.”

Kirsten
KEVEYIS patient
Hear more about Kirsten ➞
Dennis
On KEVEYIS since 2016
“Before KEVEYIS, I was having a lot of episodes…it was horrible. [After starting KEVEYIS], I haven’t had a serious attack in years.”

Dennis
KEVEYIS patient
Hear more about Dennis ➞
Janine
On KEVEYIS since 2016
“Having more control over my symptoms on KEVEYIS I feel more confident, more independent.”

Janine
KEVEYIS patient
Hear more about Janine ➞
Take the next step

Get expert
support for you
and your patients

Simply complete the form and a KEVEYIS representative will be in touch.

By submitting this form, I give permission for a Xeris Pharmaceuticals® representative to contact me by the following methods, but not limited to: phone, email, or text message. I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to, mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals Terms of Use and Privacy Statement.

Thank you!

We’ve received your message and will be in touch shortly.

References

  1. KEVEYIS [package insert]. Chicago, IL; Xeris Pharmaceuticals.
  2. Sansone VA, Burge J, McDermott MP, et al; for the Muscle Study Group. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86:1408-1416.
  3. Charles G, Zheng C, Lehmann-Horn F, Jurkat-Rott K, Levitt J. Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals. J Neurol. 2013;260:2606-2613.
  4. Cavel-Greant D, Lehmann-Horn F, Jurkat-Rott K. The impact of permanent muscle weakness on quality of life in periodic paralysis: a survey of 66 patients. Acta Myol. 2012;31:126–133.

Find answers

Take the next step

Get customized support for your KEVEYIS journey. Simply fill out the information and a Patient Access Manager will contact you. They will walk you through the entire process, from diagnosis to treatment and beyond.

By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.

Thank you!

We’ve received your message and will be in touch shortly.

Please verify that you are a U.S. Healthcare Professional

I am NOT a U.S. Healthcare Professional

I am a U.S. Healthcare Professional